We are a Swiss biotech company with the vision to accelerate the access to novel therapies for patients and society. We scout for disruptive ideas, catalyse the science with state-of-the-art clinical, process, and technology know-how and we partner for commercialisation. We accelerate the transfer of breakthrough science to the patient with an innovative manufacturing platform.

We bridge the gap between academia and commercially ready therapies. We collaborate with academia early on to take innovative science onto our manufacturing platform to accelerate the transfer from pre-clinical studies to safety, efficacy, and registration studies. We partner with regional and global institutions for market and patient access. We are a highly networked company with a core team of experienced cell and gene experts.